Lipe & Dalton Danaher Corp Transaction History

Lipe & Dalton

$198 Million
Q3 2024

A detailed history of Lipe & Dalton transactions in Danaher Corp stock. As of the latest transaction made, Lipe & Dalton holds 21,653 shares of DHR stock, worth $5 Million. This represents 3.04% of its overall portfolio holdings.

Number of Shares

21,653

Previous 21,649 0.02%

Holding current value

$5 Million

Previous $5.41 Million 11.3%

% of portfolio

3.04%

Previous 2.91%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	BUY	$239.25 - $280.76 $957 - $1,123	4 Added 0.02%	21,653 $6.02 Million
Q2 2024 Aug 02, 2024	SELL	$235.51 - $267.98 $170,980 - $194,553	-726 Reduced 3.24%	21,649 $5.41 Million
Q1 2024 May 07, 2024	SELL	$224.58 - $256.19 $7,860 - $8,966	-35 Reduced 0.16%	22,375 $5.59 Million
Q2 2023 Jul 26, 2023	SELL	$224.99 - $256.14 $89,996 - $102,456	-400 Reduced 1.75%	22,410 $5.38 Million
Q1 2023 May 02, 2023	SELL	$239.75 - $277.0 $245,743 - $283,925	-1,025 Reduced 4.3%	22,810 $5.75 Million
Q4 2022 Feb 03, 2023	SELL	$241.42 - $282.29 $27,763 - $32,463	-115 Reduced 0.48%	23,835 $6.33 Million
Q3 2022 Nov 07, 2022	BUY	$247.06 - $1507.4 $61,765 - $376,850	250 Added 1.05%	23,950 $6.19 Million
Q2 2022 Aug 01, 2022	SELL	$237.11 - $299.66 $11,855 - $14,983	-50 Reduced 0.21%	23,700 $6.01 Million
Q1 2022 Apr 26, 2022	SELL	$257.27 - $315.76 $317,728 - $389,963	-1,235 Reduced 4.94%	23,750 $6.97 Million
Q4 2021 Feb 01, 2022	BUY	$292.08 - $329.01 $92,589 - $104,296	317 Added 1.29%	24,985 $8.22 Million
Q3 2021 Nov 01, 2021	BUY	$272.21 - $332.43 $111,606 - $136,296	410 Added 1.69%	24,668 $7.51 Million
Q2 2021 Aug 02, 2021	SELL	$225.08 - $271.69 $13,504 - $16,301	-60 Reduced 0.25%	24,258 $6.51 Million
Q1 2021 Apr 30, 2021	SELL	$212.38 - $245.9 $175,213 - $202,867	-825 Reduced 3.28%	24,318 $5.47 Million
Q4 2020 Jan 29, 2021	SELL	$212.5 - $245.46 $72,250 - $83,456	-340 Reduced 1.33%	25,143 $5.59 Million
Q3 2020 Oct 30, 2020	SELL	$177.16 - $215.33 $52,262 - $63,522	-295 Reduced 1.14%	25,483 $5.49 Million
Q2 2020 Aug 07, 2020	SELL	$128.7 - $176.83 $36,036 - $49,512	-280 Reduced 1.07%	25,778 $4.56 Million
Q1 2020 May 01, 2020	SELL	$121.39 - $169.05 $126,245 - $175,812	-1,040 Reduced 3.84%	26,058 $3.61 Million
Q4 2019 Jan 21, 2020	SELL	$133.47 - $153.48 $4,004 - $4,604	-30 Reduced 0.11%	27,098 $4.16 Million
Q3 2019 Nov 07, 2019	SELL	$135.4 - $146.47 $1.1 Million - $1.19 Million	-8,128 Reduced 23.05%	27,128 $3.92 Million
Q2 2019 Jul 24, 2019	SELL	$124.88 - $143.73 $16,234 - $18,684	-130 Reduced 0.37%	35,256 $5.04 Million
Q1 2019 Apr 30, 2019	SELL	$97.62 - $132.29 $122,025 - $165,362	-1,250 Reduced 3.41%	35,386 $4.67 Million
Q4 2018 Feb 08, 2019	SELL	$94.85 - $109.54 $20,108 - $23,222	-212 Reduced 0.58%	36,636 $3.78 Million
Q3 2018 Nov 05, 2018	SELL	$98.13 - $108.9 $39,252 - $43,560	-400 Reduced 1.07%	36,848 $4 Million
Q2 2018 Aug 06, 2018	SELL	$96.1 - $103.24 $91,775 - $98,594	-955 Reduced 2.5%	37,248 $3.68 Million
Q1 2018 May 04, 2018	SELL	$92.16 - $103.8 $81,377 - $91,655	-883 Reduced 2.26%	38,203 $3.74 Million
Q4 2017 Feb 13, 2018	SELL	$85.26 - $94.62 $64,371 - $71,438	-755 Reduced 1.9%	39,086 $3.63 Million
Q3 2017 Nov 03, 2017	SELL	$79.29 - $88.45 $40,834 - $45,551	-515 Reduced 1.28%	39,841 $3.42 Million
Q2 2017 Aug 08, 2017	BUY	N/A	40,356	40,356 $3.41 Million

Others Institutions Holding DHR

# of Institutions

2,511

Shares Held

540M

Call Options Held

7.07M

Put Options Held

4.55M

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $168B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lipe & Dalton, based on Form 13F filings with the SEC.

News

Stay updated on Lipe & Dalton with notifications on news.

Account